4. Imputations of memory score dataset (Wu et al. 2013) 5. Childhood socioeconomic measures dataset (Vable et al. 2017) 6. HRS core dataset 1998 (for childhood self-rated health) eAppendix 2. Estimation of risk ratio for memory impairment between participants with cancer diagnosis (2 years after cancer) and similar aged participants with no cancer diagnosis during follow-up.
The mean memory function 2 years after cancer, when cancer diagnosis was at 75 years of age, is -0.43 units (95% CI: 0.47, 0.40). The mean memory function at 77 years of age in the group with no cancer diagnosis is -0.48 units (95% CI: 0.50, 0.46). The averaged difference in memory function 2 years after diagnosis was 0.049 units (95% CI: 0.012, 0.086).
If we assume that the risk of memory impairment in the population with no cancer diagnosis is 10%, we can find the cutoff level when memory becomes impaired (threshold for memory impairment). The z-score that cuts the lower 10% of the population with no cancer is -1.28. (see Figure below) .
To estimate the risk of cognitive impairment in the cancer group if we applied the same threshold, we added the averaged difference of memory function between the two populations to the cut-off level in the population with no cancer diagnosis. The risk of memory impairment in the population with 2 years history of cancer diagnosis is the area under the curve below the z-score of -1.33 which corresponds 9.2% of the population. In other words, the impairment threshold that classifies the lower 10% of the sample without cancer as "impaired" would classify only 9.2% of the sample who were diagnosed with cancer 2 years previously. This corresponds with a risk ratio for impairment of 0.92: = ℎ ℎ = 0.092 0.1 = 0.92
